4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,160.00p
   
  • Change Today:
      15.00p
  • 52 Week High: 1,188.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 2,186
  • Market Cap: £148.54m

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

Key Personnel

CEO: Heikki Lanckriet
CFO: David John Roth
Independent Non-Executive Director: Maria Del Pilar de la Huerta
Non-Executive Chairman: Timothy Paul McCarthy
Non-Executive Dir: Hansjörg Plaggemars, Joseph Manuel Fernández

Contact Details

Address: 25 Norman Way, Over, Cambridge, United Kingdom, CB24 5QE
Phone: +44 (0)1223 967943
Website: http://www.4basebio.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BMCLYF79

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,160.00p
Change Today 15.00p
% Change 1.31 %
52 Week High 1,188.00
52 Week Low 500.00
Volume 2,186
Shares Issued 12.81m
Market Cap £148.54m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.92% below the market average69.92% below the market average69.92% below the market average69.92% below the market average69.92% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
98.61% above the market average98.61% above the market average98.61% above the market average98.61% above the market average98.61% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
34.57% below the market average34.57% below the market average34.57% below the market average34.57% below the market average34.57% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

4basebio Dividends

No dividends found

Trades for 10-May-2024

Time Volume / Share Price
16:19 1,184 @ 1,188.00p
14:13 771 @ 1,166.00p
14:24 146 @ 1,188.00p
12:37 32 @ 1,158.50p
12:22 43 @ 1,158.50p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page